about
Structure of the GH1 domain of guanylate kinase-associated protein from Rattus norvegicusThermosensitive/magnetic poly(organophosphazene) hydrogel as a long-term magnetic resonance contrast platformThermosensitive poly(organophosphazene)-paclitaxel conjugate gels for antitumor applications.Synthesis and biological evaluation of arginyl-diosgenin conjugate as a potential bone tissue engineering agent.Design, synthesis of methotrexate-diosgenin conjugates and biological evaluation of their effect on methotrexate transport-resistant cells.Protein kinase a phosphorylates Dlx3 and regulates the function of Dlx3 during osteoblast differentiation.Protein kinase A regulates the osteogenic activity of Osterix.MRI-monitored long-term therapeutic hydrogel system for brain tumors without surgical resection.Long-term theranostic hydrogel system for solid tumors.Injectable, dual cross-linkable polyphosphazene blend hydrogels.Doxorubicin-polyphosphazene conjugate hydrogels for locally controlled delivery of cancer therapeutics.Rapid photocrosslinkable thermoresponsive injectable polyphosphazene hydrogels.Design of polyphosphazene hydrogels with improved structural properties by use of star-shaped multithiol crosslinkers.Design, synthesis and evaluation of 5-substituted 1-H-tetrazoles as potent anticonvulsant agents.The biological efficiency and bioavailability of human growth hormone delivered using injectable, ionic, thermosensitive poly(organophosphazene)-polyethylenimine conjugate hydrogels.Cationic and thermosensitive protamine conjugated gels for enhancing sustained human growth hormone delivery.Dual cross-linking systems of functionally photo-cross-linkable and thermoresponsive polyphosphazene hydrogels for biomedical applicationsActivation of JNK and p38 in MCF-7 Cells and the In Vitro Anticancer Activity of Alnus hirsuta ExtractInhibitory Effects of Aucklandia lappa Decne. Extract on Inflammatory and Oxidative Responses in LPS-Treated MacrophagesTherapeutic Potential of Diosgenin and Its Major Derivatives against Neurological Diseases: Recent Advances
P50
Q27694807-9F5533DE-6735-40EC-A8B1-64CF2B61D922Q29027895-BBD109BD-4C65-42D4-A60D-014DA84146B8Q33403943-394C906F-6F6D-4561-8F44-05EC94E68EBCQ36413102-17B69071-30A9-4CF6-B947-FE7298A763E7Q38738284-584FC121-74E1-4C46-91AE-947E41112431Q38985393-D9B95ADC-FD37-47E2-AFF1-87B26844BE3FQ38987561-83350397-FBFC-42AC-832D-8889C9FD8C75Q39368377-C3B6A3E7-1D1E-4254-B34A-A679CEA7B5C2Q39424432-04B44D7F-9656-4277-8A2E-B661870D135BQ39669981-C5DB9CF3-E338-447F-B0D8-218A14C697B8Q39839182-FDE00162-276B-442B-B5DC-C0B033D6A151Q42740384-C5045C0E-AAFC-42E8-A1C0-05D2B54B7090Q42812448-A91D05F4-DB07-4867-8E05-21227DF4B5A1Q51063182-F670EA41-13EB-4A81-9B38-4E22537EA6A1Q53410932-9ACB9AC9-87E3-45F8-9114-2B1EA5A66E2BQ53492310-C26D06E0-72EE-42CE-B755-0F0F40034E8FQ84381187-34249CA9-07CF-4CD9-BE14-61F7B710750EQ89976152-FA81A78A-F457-4676-B21D-06B44B35932BQ90400543-C303437B-AFD5-4A0E-8BCC-B582B3027012Q90671783-442E1806-C0B5-4A85-9369-9D63745FBFDC
P50
description
researcher ORCID ID = 0000-0002-2452-6184
@en
wetenschapper
@nl
name
Changju Chun
@ast
Changju Chun
@en
Changju Chun
@es
Changju Chun
@nl
type
label
Changju Chun
@ast
Changju Chun
@en
Changju Chun
@es
Changju Chun
@nl
prefLabel
Changju Chun
@ast
Changju Chun
@en
Changju Chun
@es
Changju Chun
@nl
P106
P1153
26021129600
55436084500
P31
P496
0000-0002-2452-6184